Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Independent opinions of independent directors on relevant matters
In accordance with the guiding opinions on the establishment of independent director system in listed companies, the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange, the articles of association of Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as the “company”), the working system of independent directors and other relevant laws, regulations and rules of the China Securities Regulatory Commission, As an independent director of the company, we express the following independent opinions on the relevant matters considered at the 21st Meeting of the Fifth Board of directors of the company:
1、 Independent opinions on the election of the chairman of the company and the change of the legal representative
After reviewing and verifying Mr. Liang Jiansheng’s resume and other materials, we believe that his qualifications meet the requirements for serving as the chairman of the company. Mr. Liang Jiansheng has the professional quality required for serving as the chairman of the company and is competent for the responsibilities of the position he is employed. The nomination and appointment procedures of Mr. Liang Jiansheng by the board of directors of the company comply with the provisions of the company law and the articles of association. We agree that the board of directors of the company shall elect Mr. Liang Jiansheng as the chairman of the company. 2、 Independent opinions on adding and adjusting members of special committees under the 5th board of directors
We believe that the staffing of the special committees of the board of directors meets the requirements of relevant laws and regulations, the qualifications of relevant personnel meet the conditions for holding relevant positions of the special committees of the board of directors, and the relevant personnel have professional quality and professional ethics suitable for their exercise of functions and powers, and are competent for their post responsibilities. We agree to add and adjust the members of the special committee under the Fifth Board of directors of the company.
3、 Independent opinions on the appointment of the company’s general counsel
After reviewing and verifying Mr. Cui Dan’s resume and other materials, we believe that he has strong ability to perform his duties and corresponding qualifications. We have not found that he is prohibited from taking office by the company law and other regulations, and has not been lifted by the CSRC. The nomination and appointment procedures of Mr. Cui Dan by the board of directors of the company comply with the provisions of the company law and the articles of association. We agree that the board of directors of the company shall appoint Cui Dan, deputy general manager and Secretary of the board of directors of the company, as the general counsel of the company.
Independent directors: Chen Xujiang, Chen Geng and Li Changbi. On December 30, 2021, there is no text on this page, which is the signature page of Chongqing Lummy Pharmaceutical Co.Ltd(300006) independent directors’ independent opinions on relevant matters
Chen Xujiang, Chen Geng, Li Changbi
December 30, 2021
